Daniel Kulp

About Daniel Kulp

Dan Kulp is currently Executive Director of Access Strategy for the Cardiovascular, Renal and Metabolic (CVMR) franchise at AstraZeneca. Dan leads a team responsible for optimizing access, affordability and patient services across rare disease, hospital and retail products.Previously, Dan served as the Senior Director of Access Strategy for ANDEXXA and baxdrostat, responsible for optimizing patient access for in-line and pre-launch assets with focus on both the hospital/IDN and retail setting. Prior to that Dan was the Global/US Senior Director of Insights, Analytics and Forecasting for AstraZeneca\'s CardioRenal brands. Dan lead the Global and US IA & F teams support FARXIGA, LOKELMA and baxdrostat in delivering market research, secondary data analysis and forecasts that define and enable marketing strategies.In prior roles, Dan served as both National Account Director for Acute Care GPO & Long-Term Care (LTC) customers and as Regional Account Director for large regional health plans. Dan served as the primary contact facilitating the sharing of clinical and business information and lead the implementation of several value-based contracts (aka outcomes-based contracts). Other past roles include- Contract Strategy Director (CSD), responsible for developing and executing strategies to maximize access and minimize price erosion - Brand Insight Director, Diabetes, responsible for evaluating market and brand performance for both the injectable and oral franchises. Dan was responsible for primary and secondary research, brand performance evaluation and promotional resource allocation decisions- Marketing Leader responsible for the strategies and promotional opportunities for the CV Lipids portfolio (CRESTOR and EPANOVA). Dan was responsible for the creation and implementation of the marketing plan with managed markets customers which drove paradigm breaking performance after generic entry at CRESTOR LOE.Dan\'s career began in management consulting with Andersen Consulting/Accenture and steadily progressed gaining experience across a broad spectrum of functional areas within several large pharmaceutical companies.

Experience

1. Executive Director, Access Strategy (Cvrm)

   AstraZeneca

   Sep 2025 — Present · Wilmington, DE, US

Education

• Lehigh University

  Bachelors of Science, Civil Engineering

  1993 — 1997

Skills

• Management Consulting
• Management
• Business Planning
• Team Leadership
• Strategic Planning
• Project Management
• Sales Operations
• Pharmaceuticals
• Pharmaceutical Industry
• Sales Effectiveness
• Project Portfolio Management
• Program Management
• Healthcare
• Market Analysis
• Training
• Forecasting
• Business Analysis
• Process Improvement
• Analytics
• Business Strategy
• Strategy
• Cross-Functional Team Leadership
• Competitive Analysis
• Leadership